Price $10.41 |
Market Cap
194.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
27.6
|
P/B
1.92
|
P/S
0.59
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
10.5
|
Op. Cash Flow
21K
|
FCF
1.3
|
|
Op. Margin
6.30%
|
Net Margin
2.20%
|
ROE
7.50%
|
ROI
22.70%
|
|
ROA
2.40%
|
EPS Growth
-68.30%
|
Current Ratio
1.1
|
Debt/Equity
22.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
